WELLS FARGO & COMPANY/MN - COEPTIS THERAPEUTICS HLDGS I ownership

Back to all holdings Add to watchlist

COEPTIS THERAPEUTICS HLDGS I's ticker is and the CUSIP is 19207A116. A total of 20 filers reported holding COEPTIS THERAPEUTICS HLDGS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of COEPTIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2023$2
-100.0%
100
-99.9%
0.00%–
Q2 2023$10,924
-51.3%
152,3540.0%0.00%–
Q1 2023$22,427
+47.4%
152,3540.0%0.00%–
Q4 2022$15,220–152,354–0.00%–
 Download
Other shareholders
COEPTIS THERAPEUTICS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
Ionic Capital Management LLC 518,728$11,7230.00%
METEORA CAPITAL, LLC 148,443$3,3550.00%
WELLS FARGO & COMPANY/MN 100$20.00%
WOLVERINE ASSET MANAGEMENT LLC 32,489$7340.00%
Walleye Trading LLC 72,560$1,6400.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 150,000$3,3900.00%
HRT FINANCIAL LP 102,163$30.00%
Hunting Hill Global Capital, LLC 16,382$3700.00%
CLEAR STREET LLC 1,600$00.00%
Walleye Capital LLC 109,050$2,4650.00%
View complete list of COEPTIS THERAPEUTICS HLDGS I shareholders